Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes

0 avis

Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes

Archive ouverte

Edité par CCSD ; Elsevier Masson -

International audience. Electronic word count (without references and figures legends): 6360 Number of figures: 6 Number of supplementary figures: 14 Competing financial interest none Revised Manuscript-Clear version (Will be published) Click here to view linked References

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Inducers of NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity in vitro

Archive ouverte | Michelet, Maud | CCSD

International audience. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the def...

Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms

Archive ouverte | Lucifora, Julie | CCSD

International audience. Background & Aims: Chronic co-infection with hepatitis B and D viruses (HBV and HDV) leads to the most aggressive form of chronic viral hepatitis. Here, we aimed at elucidating the molecu...

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

Archive ouverte | Chabrolles, Hélène | CCSD

International audience. Despite the existence of a preventive vaccine, chronic infection with Hepatitis B virus (HBV) affects more than 250 million people and represents a major global cause of hepatocellular carcin...

Chargement des enrichissements...